Genmab A/SGMABNASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank64
3Y CAGR-18.5%
5Y CAGR-8.6%
Studio
Year-over-Year Change

Pre-tax earnings

3Y CAGR
-18.5%/yr
vs +44.1%/yr prior
5Y CAGR
-8.6%/yr
Recent deceleration
Acceleration
-62.6pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$3.76B-59.0%
2024$9.16B+62.6%
2023$5.64B-18.8%
2022$6.95B+77.3%
2021$3.92B-33.6%
2020$5.90B+106.5%
2019$2.86B+77.4%
2018$1.61B+51.5%
2017$1.06B-5.9%
2016$1.13B-